Table of Contents 1 RESEARCH SCOPE 1.1 Research Product Definition 1.2 Research Segmentation 1.2.1 Product Type 1.2.2 Main product Type of Major Players 1.3 Demand Overview 1.4 Research Methodology 2 GLOBAL 5 NUCLEOTIDASE INDUSTRY 2.1 Summary about 5 Nucleotidase Industry 2.2 5 Nucleotidase Market Trends 2.2.1 5 Nucleotidase Production & Consumption Trends 2.2.2 5 Nucleotidase Demand Structure Trends 2.3 5 Nucleotidase Cost & Price 3 MARKET DYNAMICS 3.1 Manufacturing & Purchasing Behavior in 2020 3.2 Market Development under the Impact of COVID-19 3.2.1 Drivers 3.2.2 Restraints 3.2.3 Opportunity 3.2.4 Risk 4 GLOBAL MARKET SEGMENTATION 4.1 Region Segmentation (2017 to 2021f) 4.1.1 North America (U.S., Canada and Mexico) 4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe) 4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific) 4.1.4 South America (Brazil,, Argentina, Rest of Latin America) 4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa) 4.2 Product Type Segmentation (2017 to 2021f) 4.2.1 CPX-006 4.2.2 IPH-53 4.2.3 AB-680 4.2.4 BMS-986179 4.2.5 Others 4.3 Consumption Segmentation (2017 to 2021f) 4.3.1 Colorectal Cancer 4.3.2 Fallopian Tube Cancer 4.3.3 Gastric Cancer 4.3.4 Metastatic Colorectal Cancer 4.3.5 Others 5 NORTH AMERICA MARKET SEGMENT 5.1 Region Segmentation (2017 to 2021f) 5.1.1 U.S. 5.1.2 Canada 5.1.3 Mexico 5.2 Product Type Segmentation (2017 to 2021f) 5.2.1 CPX-006 5.2.2 IPH-53 5.2.3 AB-680 5.2.4 BMS-986179 5.2.5 Others 5.3 Consumption Segmentation (2017 to 2021f) 5.3.1 Colorectal Cancer 5.3.2 Fallopian Tube Cancer 5.3.3 Gastric Cancer 5.3.4 Metastatic Colorectal Cancer 5.3.5 Others 5.4 Impact of COVID-19 in North America 6 EUROPE MARKET SEGMENTATION 6.1 Region Segmentation (2017 to 2021f) 6.1.1 Germany 6.1.2 UK 6.1.3 France 6.1.4 Italy 6.1.5 Rest of Europe 6.2 Product Type Segmentation (2017 to 2021f) 6.2.1 CPX-006 6.2.2 IPH-53 6.2.3 AB-680 6.2.4 BMS-986179 6.2.5 Others 6.3 Consumption Segmentation (2017 to 2021f) 6.3.1 Colorectal Cancer 6.3.2 Fallopian Tube Cancer 6.3.3 Gastric Cancer 6.3.4 Metastatic Colorectal Cancer 6.3.5 Others 6.4 Impact of COVID-19 in Europe 7 ASIA-PACIFIC MARKET SEGMENTATION 7.1 Region Segmentation (2017 to 2021f) 7.1.1 China 7.1.2 India 7.1.3 Japan 7.1.4 South Korea 7.1.5 Southeast Asia 7.1.6 Australia 7.1.7 Rest of Asia Pacific 7.2 Product Type Segmentation (2017 to 2021f) 7.2.1 CPX-006 7.2.2 IPH-53 7.2.3 AB-680 7.2.4 BMS-986179 7.2.5 Others 7.3 Consumption Segmentation (2017 to 2021f) 7.3.1 Colorectal Cancer 7.3.2 Fallopian Tube Cancer 7.3.3 Gastric Cancer 7.3.4 Metastatic Colorectal Cancer 7.3.5 Others 7.4 Impact of COVID-19 in Europe 8 SOUTH AMERICA MARKET SEGMENTATION 8.1 Region Segmentation (2017 to 2021f) 8.1.1 Brazil 8.1.2 Argentina 8.1.3 Rest of Latin America 8.2 Product Type Segmentation (2017 to 2021f) 8.2.1 CPX-006 8.2.2 IPH-53 8.2.3 AB-680 8.2.4 BMS-986179 8.2.5 Others 8.3 Consumption Segmentation (2017 to 2021f) 8.3.1 Colorectal Cancer 8.3.2 Fallopian Tube Cancer 8.3.3 Gastric Cancer 8.3.4 Metastatic Colorectal Cancer 8.3.5 Others 8.4 Impact of COVID-19 in Europe 9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION 9.1 Region Segmentation (2017 to 2021f) 9.1.1 GCC 9.1.2 North Africa 9.1.3 South Africa 9.1.4 Rest of Middle East and Africa 9.2 Product Type Segmentation (2017 to 2021f) 9.2.1 CPX-006 9.2.2 IPH-53 9.2.3 AB-680 9.2.4 BMS-986179 9.2.5 Others 9.3 Consumption Segmentation (2017 to 2021f) 9.3.1 Colorectal Cancer 9.3.2 Fallopian Tube Cancer 9.3.3 Gastric Cancer 9.3.4 Metastatic Colorectal Cancer 9.3.5 Others 9.4 Impact of COVID-19 in Europe 10 COMPETITION OF MAJOR PLAYERS 10.1 Brief Introduction of Major Players 10.1.1 Bristol-Myers Squibb Co 10.1.2 Corvus Pharmaceuticals Inc 10.1.3 Innate Pharma SA 10.1.4 MedImmune LLC 10.1.5 Surface Oncology Inc 10.2 5 Nucleotidase Sales Date of Major Players (2017-2020e) 10.2.1 Bristol-Myers Squibb Co 10.2.2 Corvus Pharmaceuticals Inc 10.2.3 Innate Pharma SA 10.2.4 MedImmune LLC 10.2.5 Surface Oncology Inc 10.3 Market Distribution of Major Players 10.4 Global Competition Segmentation 11 MARKET FORECAST 11.1 Forecast by Region 11.2 Forecast by Demand 11.3 Environment Forecast 11.3.1 Impact of COVID-19 11.3.2 Geopolitics Overview 11.3.3 Economic Overview of Major Countries 12 REPORT SUMMARY STATEMENT

List of Table 1.Table 5 Nucleotidase Product Type Overview 2.Table 5 Nucleotidase Product Type Market Share List 3.Table 5 Nucleotidase Product Type of Major Players 4.Table Brief Introduction of Bristol-Myers Squibb Co 5.Table Brief Introduction of Corvus Pharmaceuticals Inc 6.Table Brief Introduction of Innate Pharma SA 7.Table Brief Introduction of MedImmune LLC 8.Table Brief Introduction of Surface Oncology Inc 9.Table Products & Services of Bristol-Myers Squibb Co 10.Table Products & Services of Corvus Pharmaceuticals Inc 11.Table Products & Services of Innate Pharma SA 12.Table Products & Services of MedImmune LLC 13.Table Products & Services of Surface Oncology Inc 14.Table Market Distribution of Major Players 15.Table Global Major Players Sales Revenue (Million USD) 2017-2020e 16.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e 17.Table Global 5 Nucleotidase Market Forecast (Million USD) by Region 2021f-2026f 18.Table Global 5 Nucleotidase Market Forecast (Million USD) Share by Region 2021f-2026f 19.Table Global 5 Nucleotidase Market Forecast (Million USD) by Demand 2021f-2026f 20.Table Global 5 Nucleotidase Market Forecast (Million USD) Share by Demand 2021f-2026f